Small-Cap Momentum Watch: Upcoming Catalysts for July 6–10
7/5/20264 min read
From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week.
--
Companies with Material Events:
● VERI – Will host its 2026 Innovation Showcase on July 7 at 3:00 PM ET, where management will present the company's latest enterprise AI solutions, including product demonstrations, customer use cases, future growth opportunities, and strategic updates.
● NCPL – Will host an investor conference call on July 7 at 4:30 PM ET. CEO Todd Violette will provide updates on recent acquisitions, integration efforts, strategic initiatives, and the company's long-term growth pipeline.
● ACXP – Announced plans to begin a new open-label pilot trial evaluating ibezapolstat (IBZ) in patients with multiply recurrent C. difficile infection. Results from the pilot are intended to support a planned Phase 3 registration study under the FDA's Limited Population Pathway. Additionally, new preclinical data has been submitted for presentation at the Anaerobe Society of the Americas Conference, taking place July 7–10 at Columbia University in New York, with results expected to be publicly released shortly afterward.
● QNC – Will participate as a sponsor at the AI for Good Global Summit, held July 8–11 in Geneva, Switzerland. The United Nations-backed event brings together global AI leaders, policymakers, and industry experts to discuss practical AI applications, cybersecurity, healthcare, digital inclusion, and ethical AI.
● NYXH – Will host an Investor & Analyst Day on July 8 from 10:00 AM–12:30 PM ET in New York. Management is expected to provide updates on the company's obstructive sleep apnea platform, strategic outlook, and commercialization progress. The event will also be webcast with live Q&A.
● SFIX – Management will participate in the Bernstein Insights: 2nd Annual Retail Forum on July 8 in New York City, engaging with institutional investors.
● ESPR – Will hold a virtual Special Meeting of Stockholders on July 8 at 8:00 AM ET to vote on the proposed acquisition by an affiliate of ArchiMed. Shareholders will vote on approval of the merger agreement, executive compensation related to the transaction, and a potential meeting adjournment if additional votes are required. If approved, shareholders would receive $3.16 per share in cash plus one contingent value right (CVR) tied to future milestone payments.
● LOAN – Shareholders of record on July 8 will receive a previously declared $0.11 per share cash dividend, payable July 15, 2026.
● KPRX – Will participate in a Piper Sandler Virtual Ophthalmology Symposium fireside chat on July 9 at 2:30 PM ET, providing updates on its ophthalmology pipeline.
● ZENA – Will present at the Global Technology Virtual Investor Conference on July 9, discussing the company's Drone-as-a-Service expansion, defense drone initiatives, and growth strategy while conducting one-on-one investor meetings.
● OCGN – Will participate in a Piper Sandler Virtual Ophthalmology Day fireside chat on July 10 from 10:00–10:25 AM ET, where management will discuss its modifier gene therapy platform and broader ophthalmology pipeline.
● EVAX – Will present new preclinical data on its AI-designed EVX-V1 cytomegalovirus (CMV) vaccine at the International Herpesvirus Workshop, taking place July 11–15 in Montreal, Canada. The poster presentation is scheduled for July 12 from 9:30–11:30 AM ET and will highlight AI-driven antigen selection supporting development of a next-generation CMV vaccine.
● MMA – Will relaunch MixedMartialArts.com with new original content surrounding UFC International Fight Week and the July 11 return of Conor McGregor. The relaunch includes an exclusive interview featuring coach John Kavanagh and UFC broadcaster Laura Sanko ahead of fight week.
● CVKD – Will present late-breaking Phase 2 clinical data on CAD-1005, its first-in-class 12-lipoxygenase inhibitor for heparin-induced thrombocytopenia (HIT), at the International Society on Thrombosis and Haemostasis (ISTH) Congress in Paris, July 11–15. The oral presentation is scheduled for July 12 at 11:15 AM CEST after being selected for the congress' prestigious Late-Breakthrough Clinical Trials session, highlighting one of the first randomized, placebo-controlled studies in HIT.
● AQMS – Executive leadership will participate in the NAATBatt International 2026 Recycling & Lifecycle Management Workshop, held July 7–9 at Michigan State University. CEO Steve Cotton will deliver a featured presentation on July 7 focused on lithium iron phosphate (LFP) battery recycling and circular supply chains before joining an executive panel on the future of battery recycling.
● GAME – Will produce the 2026 World of Dance Summit, taking place July 7–10 at the Anaheim Convention Center. The event is expected to attract competitors from more than 50 countries, while the company also serves as the official sales and marketing agency for World of Dance, expanding its presence across live entertainment and media.
--
Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.
Disclaimer: Penny stock trading involves substantial risk, so always research every alert before trading, consult with a licensed professional before trading, only invest what you can afford to lose, and always trade with caution. Readers should independently investigate and fully understand all risks before investing. Results listed are NOT typical and individual results may and most likely will vary. Bigtimepennystocks.com and its staff are NOT licensed investment advisors or broker/dealers of any kind.Alerts are not a solicitation or recommendation to buy/sell/hold securities but merely investment ideas that should NEVER serve as the basis of your trading decisions. Bigtimepennystocks.com and its newsletter are for entertainment purposes only. This website and its reports are for general information purposes as we are engaged in the business of marketing and advertising companies for monetary compensation. Any investment decision should be discussed with a financial adviser before taking place. Please invest carefully and read investment information available at the website of the SEC at http://www.sec.gov.
Subscribe to our Free Newsletter
Copyright © 2023 BigTimePennyStocks.com - All Rights Reserved.